News and Announcements
Chris Weddle of Unido
- Published December 06, 2022 7:00AM UTC
- Publisher Maan Perez
- Categories Executive Interviews
Unido enables individuals and businesses to seamlessly manage and invest in DeFi and crypto markets, by providing an enterprise-grade platform with DeFi and crypto banking management tools.
Watch this interview with CEO Chris Weddle as he shares how he was able to come up with a solution that can help investors access the crypto markets.
Unido
Unido offers a secure platform for sharing and managing digital assets through its user-friendly self-custody solution. Utilizing patented multi-party computation (MPC) technology, Unido ensures both security and group consensus for Individuals, SMBs, and Enterprises. The company’s diverse…
Executive Interviews
12.25% Total Returns? This Trust’s Fuel and Convenience Strategy Is Pumping Up Profits
The Queensland Property Strategy Turning Heads—And Profits In the world of commercial property investment, finding the next big opportunity is like striking gold. And right now, there’s a gold rush happening in Queensland, with Amplify, a Queensland-based Funds Manager, leading the charge. Let’s cut through the noise and see what’s really going on. The Amplify […]
A Nation Divided: Insights from Our Subscriber Poll on the Upcoming U.S. Election
October 20, 2024 This entire post was created by ChatGPT o1 utilising the data and comments from the poll. The world watches closely as the United States stands on the brink of a consequential presidential election. The outcome will shape America’s future and have profound implications for the global economy and international relations. To capture […]
A New Era of Investment in Australia’s Life Science Sector
In just six months, four new investment funds have emerged, all targeting Australia’s life sciences and healthcare companies. With scientific advancements, government backing, and structural undervaluation, these funds represent a significant moment for the sector—offering investors a rare opportunity to capitalise on growth in biotech and medtech.
Backed By Leading Investment Groups and Family Offices
